Skip to main content
. Author manuscript; available in PMC: 2014 Jun 1.
Published in final edited form as: Invest New Drugs. 2012 Nov 15;31(3):769–773. doi: 10.1007/s10637-012-9897-4

Table 2.

Observed Grade 1–2 Toxicities

Grade 1–2 Toxicity Number Percent (%)
Fatigue 18 78
Hyperglycemia 17 74
Anemia 14 61
Diarrhea 13 57
Anorexia 10 43
Hypocalcemia 10 43
Nausea 10 43
Hyponatremia 9 39
Increased AST/ALT 7 30
Lymphopenia 6 26
Thrombocytopenia 5 22
Vomiting 5 22